Longterm Followup Assessment of a HER2/neu Peptide (E75) Vaccine for Prevention of Recurrence in High-Risk Prostate Cancer Patients-Reference-Cited by-同舟云学术

Longterm Followup Assessment of a HER2/neu Peptide (E75) Vaccine for Prevention of Recurrence in High-Risk Prostate Cancer Patients

Published:2009-02 Issue:2 Volume:208 Page:193-201
ISSN:1072-7515
Container-title:Journal of the American College of Surgeons
language:en
Short-container-title:Journal of the American College of Surgeons

Author:

Gates Jeremy D.,Carmichael Mark G.,Benavides Linda C.,Holmes Jarrod P.,Hueman Matthew T.,Woll Michael M.,Ioannides Constantine G.,Robson Craig H.,McLeod David G.,Ponniah Sathibalan,Peoples George E.

Publisher

Elsevier BV

Subject

Surgery

Reference38 articles.

1. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2;Slamon;N Engl J Med,2001

2. Her-2-neu expression and progression toward androgen independence in human prostate cancer;Signoretti;J Natl Cancer Inst,2000

3. Phase I clinical trial of a HER-2/neu peptide (E75) vaccine for the prevention of prostate-specific antigen recurrence in high-risk prostate cancer patients;Hueman;Clin Cancer Res,2005

4. Peptide priming of cytolytic activity to HER-2 epitope 369−377 in healthy individuals;Anderson;Clin Cancer Res,2000

5. Identification of Her-2/Neu CTL epitopes using double transgenic mice expressing HLA-A2.1 and human CD. 8;Lustgarten;Hum Immunol,1997

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Application of HER2 peptide vaccines in patients with breast cancer: a systematic review and meta-analysis;Cancer Cell International;2021-09-15

2. Immunotherapy as a Precision Medicine Tool for the Treatment of Prostate Cancer;Cancers;2021-01-06

3. Personalized Management of Cancers of Various Organs/Systems;Textbook of Personalized Medicine;2020-12-06

4. Correlation of Gleason Grading and Prognostic Immunohistochemistry Markers (Human Epidermal Growth Factor Receptor 2/neu and Androgen Receptor) in Prostatic Core Needle Biopsy: A Study in a Tertiary Care Center;Indian Journal of Medical and Paediatric Oncology;2019-04

5. HER2/neu;Cancer Therapeutic Targets;2017